 | ||||||||||||||
 |
|
|
| |||||||||||
|
| ||||||||||||||
|
|
|
| |
|
| |||
|
|
Day I: Asia Pacific Pharma Congress Tuesday, September 10, 2013 |
|
|
| ||
|
|
OPENING PLENARY SESSION |
| |||
|
|
1:00 p.m.  |
|
Welcome and Introductions: Asia Pacific Pharma Congress Vision and Overview: Implementing Compliance Best Practices Across an Immense Geographic Region with Many Cultural Differences Overview Gareth Lee, Esq. General Counsel & Head of Compliance, Asia Pacific, Allergan Inc., Singapore (Co-chair) |
| |
|
|
 |
|
Comments Abdul Luheshi, MBA Vice President Health Care Compliance, Asia Pacific, Johnson & Johnson, Singapore (Co-chair) |
| |
|
|
 |
|
Maria "Maru" Quindimil, MBA Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Manila, Philippines (Co-chair) |
| |
|
|
 |
|
Tom M. Zerull Regional Compliance Director, Asia, Australia, Africa, Middle East & Japan, AbbVie; Former Regional Director, Asia Pacific, Office of Ethics & Compliance, Abbott, Singapore (Co-chair) |
| |
|
|
 |
|
|
|
|
|
|
1:30 p.m.  |
|
Keynote Address: Integrity as a Winning Differentiator in Today's Complex and Competitive Business Landscape Ian Bell President, Allergan Asia Pacific, Singapore Presentation Material (Acrobat) |
| |
|
|
|
|
|
|
|
|
|
2:00 p.m.  |
|
External Perspectives: Overview of the Patient Perspective Kin Ping Tsang Chair, International Alliance of Patients Organizations (IAPO), Founder, Retina Hong Kong, Past Chair, Alliance for Patients Mutual Help Organizations (APMHO), Hong Kong Presentation Material (Acrobat) |
| |
|
|
|
|
|
|
|
|
|
2:30 p.m.  |
|
External Perspectives: Overview of the Health Care Professional (HCP) Perspective Prof. Dr. Agus Purwadianto, MD, JD, PhD Senior Staff on Legal & Human Rights Affairs, Coordinating Ministry for People's Welfare, Indonesia; Expert Staff for Medico-Legal, Minister of Health, Government of Indonesia; Member, Commission for Bioethics Member, Medical Ethics Board, Indonesian Doctors Association, Jakarta, Indonesia Presentation Material (Acrobat) |
| |
|
|
|
|
|
|
|
|
|
3:00 p.m.  |
|
External Perspectives: Overview of the Distributor Perspective Andrew Frye, MBA Vice President, DKSH Healthcare; Former Commercial Director, Pharma, Abbott Laboratories, Bangkok, Thailand |
| |
|
|
|
|
|
|
|
|
|
3:30 p.m.  |
|
External Perspectives Roundtable and Q&A Robert Skinner, PhD Deputy Compliance Officer, Emerging Markets, Asia Pacific & Japan, GlaxoSmithKline, Chalfont St Giles, Buckinghamshire, UK (Moderator) |
| |
|
|
|
|
|
|
|
|
|
4:00 p.m. |
|
Break |
| |
|
|
|
|
|
|
|
|
|
4:30 p.m.  |
|
Overview of the Role of Voluntary Codes in Facilitating Compliance and Ethical Behavior Russell Williams President of Rx&D Canada; Chair, IFPMA Code Compliance Network; Former Member, National Assembly of Quebec, Ottawa, Canada Presentation Material (Acrobat) |
| |
|
|
|
|
|
|
|
|
|
4:45 p.m.  |
|
Asia Pacific Code Roundtable Presentation Material (Acrobat) Alan Chin Ethics & Compliance Officer, Malaysia & Singapore, Eli Lilly; Co-Chair, Marketing Practices Committee, Singapore Association of Pharmaceutical Industries (SAPI), Singapore |
| |
|
|
 |
|
Hwa-Soo Chung, Esq. Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea |
| |
|
|
 |
|
Yota Kikuchi Manager, Promotion Code & Public Affairs, sanofi-aventis; Vice Chairman, Code Practices Committee, Japan Pharmaceutical Manufacturers Association (JPMA); Member, IFPMA Code Compliance Network, Tokyo, Japan Presentation Material (Acrobat) |
| |
|
|
 |
|
Deborah Monk Director, Compliance, Medicines Australia; Manager, Medicines Australia's Code of Conduct, Deakin, Australian Capital Territory, Australia Presentation Material (Acrobat) |
| |
|
|
 |
|
Roj Rungvisai Head of Legal and Compliance, Novartis Thailand, Chairman, Code Compliance Subcommittee, Pharmaceutical Research and Manufacturers Association (PReMA), Bangkok, Thailand |
| |
|
|
 |
|
Parulian Simanjuntak Executive Director, International Pharmaceutical Manufacturers Group, Jakarta, Indonesia |
| |
|
|
 |
|
Francisco P. Tranquilino, MD, FPCP Technical Consultant, Ethics Committee, Pharmaceutical and Healthcare Association of the Philippines (PHAP); Special Assistant to the Dean and College Secretary, University of the Philippines College of Medicine; Member, APEC Expert Working Group on Business Ethics in the Biopharmaceutical Sector, Manila, Philippines Presentation Material (Acrobat) |
| |
|
|
 |
|
Dr Vicknesh Welluppillai Senior Medical Director, Pfizer Malaysia, Kuala Lumpur, Malaysia |
| |
|
|
 |
|
Commentators Heather Simmonds Director and Chair, Code of Practice Panel Prescription Medicines Code of Practice Authority; Vice-Chair, IFPMA Code Compliance Network, London, UK |
| |
|
|
 |
|
Jose F. Zamarriego Izquierdo Director Unidad de Supervision Deontologica, FARMAINDUSTRIA; Member, IFPMA Code Network, Madrid, Spain |
| |
|
|
 |
|
Moderator Tamara Music Manager, Influenza Vaccines & Code Compliance, IFPMA, Geneva, Switzerland |
| |
|
|
|
|
|
|
|
|
|
6:30 p.m. |
|
Adjournment and Networking Reception |
| |
|
| |||
|
|
|
| |
|
| |||
© Health Care Conference Administrators
Contact Webmaster